Profile
Dr. Ingrid Heinze-Krauss is Chief Technology Officer at Basilea Pharmaceutica AG.
Dr. Heinze-Krauss was previously employed as Head-Medicinal Chemistry by Roche Group.
She received her doctorate degree from the University of Freiburg.
Former positions of Ingrid Heinze-Krauss
| Companies | Position | End |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Tech/Sci/R&D Officer | 2016-01-31 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Training of Ingrid Heinze-Krauss
| University of Freiburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Private companies | 1 |
|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
- Stock Market
- Insiders
- Ingrid Heinze-Krauss
